{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:32:54Z","timestamp":1773160374630,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2013,11,16]],"date-time":"2013-11-16T00:00:00Z","timestamp":1384560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00508-013-0447-7","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T07:25:24Z","timestamp":1384500324000},"page":"9-14","source":"Crossref","is-referenced-by-count":25,"title":["Non-interventional study evaluating efficacy and tolerability of rifaximin for treatment of uncomplicated diverticular disease","Nicht-interventionelle Studie zur Evaluierung der Wirksamkeit und Vertr\u00e4glichkeit von Rifaximin in der Therapie der unkomplizierten Divertikelerkrankung"],"prefix":"10.1007","volume":"126","author":[{"given":"Sylvia","family":"Stallinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Eller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"H\u00f6genauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,16]]},"reference":[{"issue":"7","key":"447_CR1","first-page":"1229","volume":"72","author":"H Salzmann","year":"2005","unstructured":"Salzmann H, Lillie D. Diverticular disease: Diagnosis and treatment. Am Fam Physician. 2005;72(7):1229\u201334.","journal-title":"Am Fam Physician"},{"issue":"5\u20136","key":"447_CR2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00508-009-1157-7","volume":"121","author":"P Kornprat","year":"2009","unstructured":"Kornprat P, Langner C, Mohadjer DJ, Mischinger H. Chicken-bone perforation of a sigmoid colon diverticulum into the right groin and subsequent phlegmonous inflammation of the abdominal wall. Wien Klin Wochenschr. 2009;121(5\u20136):220\u20132.","journal-title":"Wien Klin Wochenschr"},{"issue":"20","key":"447_CR3","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1056\/NEJMcp073228","volume":"357","author":"DO Jacobs","year":"2007","unstructured":"Jacobs DO. Clinical Practice. Diverticulitis. N Engl J Med. 2007;357(20):2057\u201366.","journal-title":"N Engl J Med"},{"key":"447_CR4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00384-002-0396-5","volume":"18","author":"G Latella","year":"2003","unstructured":"Latella G, Pimpo MT, Sottili S, et. al. Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis. 2003;18:55\u201362.","journal-title":"Int J Colorectal Dis"},{"issue":"9409","key":"447_CR5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(04)15597-9","volume":"363","author":"N Stollman","year":"2004","unstructured":"Stollman N, Raskin JP. Diverticular disease of the colon. Lancet 2004;363(9409):631\u20139.","journal-title":"Lancet"},{"key":"447_CR6","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/j.1365-2036.2006.02896.x","volume":"23","author":"L Petruzziello","year":"2006","unstructured":"Petruzziello L, Iacopini F, Bulajic M, Shah S, Costamagna G. Review article: uncomplicated diverticular disease of the colon. Aliment Pharmacol Ther. 2006;23:1379\u201391.","journal-title":"Aliment Pharmacol Ther"},{"key":"447_CR7","first-page":"257","volume":"50","author":"E Schr\u00f6pfer","year":"2010","unstructured":"Schr\u00f6pfer E, Schindler G, Thiede A, Meyer T. Diagnostik der Divertikelerkrankung. Demographie, Pathogenese, moderne Standards. Internist. 2010;50:257\u201368.","journal-title":"Internist."},{"issue":"10","key":"447_CR8","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/MCG.0b013e318188adc1","volume":"42","author":"CD Trivedi","year":"2008","unstructured":"Trivedi CD, Das KM. Emerging Therapies for Diverticular Diseases of the Colon. J Clin Gastroenterol. 2008;42(10):1145\u201351.","journal-title":"J Clin Gastroenterol"},{"key":"447_CR9","first-page":"283","volume":"8","author":"MA Pistoia","year":"2004","unstructured":"Pistoia MA, Lombardi L, Rossi M, Vittorini C, Cavaliere GF, Pistoia F. Does rifaximin prevent complications of diverticular disease? A retrospective study. Eur Rev Med Pharmacol Sci. 2004;8:283\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"447_CR10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2036.2007.03491.x","volume":"26","author":"MM Szojda","year":"2007","unstructured":"Szojda MM, Cuesta MA, Mulder CM, Felt-Bersma RJ. Review article: management of diverticulitis. Aliment Pharmacol Ther. 2007;26(2):67\u201376.","journal-title":"Aliment Pharmacol Ther"},{"key":"447_CR11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.mcg.0000124005.07433.69","volume":"38","author":"AB West","year":"2004","unstructured":"West AB, Losada M. The pathology of diverticulosis coli. J Clin Gastroenterol. 2004;38:11\u20136.","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"447_CR12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2036.2010.04530.x","volume":"33","author":"A Tursi","year":"2011","unstructured":"Tursi A, Elisei W, Giorgette GM, Aiello F, Brandimarte G. Inflammatory manifestations at colonoscopy in patients with colonic diverticular disease. Aliment Pharmacol Ther. 2011; 33(3):358\u201365.","journal-title":"Aliment Pharmacol Ther"},{"key":"447_CR13","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2036.2009.04072.x","volume":"30","author":"A Tursi","year":"2009","unstructured":"Tursi A, Papagrigoriadis S. Review article: the current and evolving treatment of colonic diverticular disease. Aliment Phamarmacol Ther. 2009;30:532\u201346.","journal-title":"Aliment Phamarmacol Ther"},{"key":"447_CR14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1590-8658(02)80110-4","volume":"34","author":"A Tursi","year":"2002","unstructured":"Tursi A, Brandimarte G, Daffin\u00e0 R. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis. 2002;34:510\u20135.","journal-title":"Dig Liver Dis"},{"issue":"2","key":"447_CR15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3748\/wjg.v13.i2.264","volume":"13","author":"A Colecchia","year":"2007","unstructured":"Colecchia A, Vestito A, Pasqui F, et al. Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease. World J Gastroenterol. 2007;13(2):264\u20139.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"447_CR16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.dld.2012.09.006","volume":"45","author":"A Lanas","year":"2013","unstructured":"Lanas A, Ponce J, Bignamini A, Mearin F. One year intermittent rifaximin plus fibre supplementation vs. fibre supplement alone to prevent diverticulitis recurrence: a proof-of-concept study. Dig Liver Dis 2013;45(2):104\u20139.","journal-title":"Dig Liver Dis"},{"issue":"12","key":"447_CR17","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","volume":"362","author":"NM Bass","year":"2010","unstructured":"Bass NM, Mullen KD, Sanyal A, Poordad F, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 2010;362(12):1071\u201381.","journal-title":"N Engl J Med"},{"key":"447_CR18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2036.1995.tb00348.x","volume":"9","author":"C Papi","year":"1995","unstructured":"Papi C, Ciaco A, Koch M, Capurso L, Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Phamacol Ther. 1995;9:33\u20139.","journal-title":"Aliment Phamacol Ther"},{"key":"447_CR19","doi-asserted-by":"crossref","unstructured":"Zaniolo O, Eandi M. Rifaximin in treatment of diverticular disease: therapeutic and economic potential. Farmeconomia e percorsi terapeutici. 2005;6(1):5\u201320.","DOI":"10.7175\/fe.v6i1.817"},{"key":"447_CR20","doi-asserted-by":"crossref","unstructured":"Hansen O, Stock W. Prophylaktische Operation bei Divertikelerkrankung des Kolons\u2014Stufenkonzept durch exakte Stadieneinteilung. Langenbecks Arch Chir (Suppl II). 1999:1257\u201360.","DOI":"10.1007\/978-3-642-60248-1_319"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-013-0447-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-013-0447-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-013-0447-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T19:54:54Z","timestamp":1564689294000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-013-0447-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,16]]},"references-count":20,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["447"],"URL":"https:\/\/doi.org\/10.1007\/s00508-013-0447-7","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,16]]}}}